Understanding Meds for CKD Patients
Jeffrey Berns talks about medication safety in patients and the importance of communicating to nonnephrologists the specific hazards in patients with kidney disease. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - April 22, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
AHA Survey: Women Still Don't Know of Their Danger
Ileana Pina talks about a new survey conducted by the American Heart Disease that shows more awareness of heart disease in women -- but there are still disparity gaps. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - April 22, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Are You Joining an ESCO? Find Out if You Should
Jeffrey Berns reports on a CMS 5-year initiative, the formation of 15 ESRD Seamless Care Organizations (ESCOs). The goal: cost savings through coordinated care for patients on dialysis. Will it work? (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - March 1, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Tolvaptan and Liver Damage Warnings: Tip of the Iceberg?
Jeffrey Berns talks about the FDA warnings concerning liver damage with the use of tolvaptan, recently approved for polycystic kidney disease. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 21, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Tolvaptan: A New Weapon for a Tough Kidney Disease
This F1000 commentary reports on a study whose findings support the use of tolvaptan to slow the progression of autosomal dominant polycystic kidney disease (ADPKD). (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 14, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Huge Shift From EPO to Iron: Worrisome
Jeffrey Berns discusses the DOPPS results on anemia management: Erythropoietin use is way down and iron administration is way up; this is probably not a good thing. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - February 6, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
How Will Nephrologists Be Affected Post-Cliff?
Jeffrey Berns talks about the changes coming in 2013 after the fiscal cliff vote that will affect the economics of nephrologists, including fees and dialysis payments. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - January 10, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
New Nephrologists: Not Made in America
Jeffrey Berns discusses the challenges of filling nephrology fellowships now and -- more disturbing -- in the future. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - January 8, 2013 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
Coming Soon: Nephrology's Very Own Fiscal Cliff
Jeff Berns talks about what lies ahead in 2013 for changes in bundled payments, including additions of new oral medications and the effects of lower use of erythropoiesis-stimulating agents. (Source: Medscape Nephrology Podcast)
Source: Medscape Nephrology Podcast - December 31, 2012 Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
